TScan Therapeutics Named the Highest-Placed Midsize Biotechnology Company in The Top Places to Work for 2022 by The Boston Globe December 1, 2022
Werewolf Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update November 15, 2022
Immunitas Therapeutics Presents Preclinical Data Demonstrating Potential of Novel Cancer Immunotherapy IMT-009 at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting November 15, 2022
TScan Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update November 15, 2022
